Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia
暂无分享,去创建一个
S. Knuutila | O. Monni | W. El‐Rifai | Y. Zhu | J. Vilpo | L. Vilpo | S. Siitonen
[1] K. Franssila,et al. Molecular characterization of deletion at 11q22.1‐23.3 in mantle cell lymphoma , 1999, British journal of haematology.
[2] J. Minna,et al. Alterations of the PPP2R1B gene in human lung and colon cancer. , 1998, Science.
[3] S. Knuutila,et al. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis , 1998, Cytogenetic and Genome Research.
[4] O. Kallioniemi,et al. Frequent loss of the 11q14‐24 region in chronic lymphocytic leukemia: A study by comparative genomic hybridization , 1997, Genes, chromosomes & cancer.
[5] M. James,et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. , 1997, Blood.
[6] B. Weissman,et al. Localization and characterization of a chromosome 11 tumor suppressor gene using organotypic raft cultures. , 1997, Cancer research.
[7] A. Børresen-Dale,et al. Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM , 1997, Genes, chromosomes & cancer.
[8] M. James,et al. Erratum: Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders (Proceedings of the National Academy of Sciences of the United States of America (October 15, 1996) 93:21 (11837-11841)) , 1996 .
[9] F. Hosoda,et al. A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2-q23.3. , 1996, Genomics.
[10] C. Fegan,et al. Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. , 1995, Leukemia.
[11] C. Mecucci,et al. Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. , 1995, Leukemia.
[12] B. Weissman,et al. A functional analysis of tumor suppressor activity for peripheral neuroepitheliomas by monochromosome transfer. , 1995, Oncogene.
[13] M. James,et al. Allelotype of head and neck paragangliomas: Allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL , 1994, Genes, chromosomes & cancer.
[14] D. Catovsky,et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. , 1994, Leukemia.
[15] G. Hampton,et al. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. , 1994, Cancer research.
[16] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[17] G. Hampton,et al. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] B. Johansson,et al. Cytogenetic deletion maps of hematologic neoplasms: Circumstantial evidence for tumor suppressor Loci , 1993, Genes, chromosomes & cancer.
[19] G. Mann,et al. Loss of heterozygosity in malignant melanoma at loci on chromosomes 11 and 17 implicated in the pathogenesis of other cancers , 1993, Genes, chromosomes & cancer.
[20] G. W. Stamp,et al. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. , 1993, British Journal of Cancer.
[21] T. Dragani,et al. 11q deletions in human colorectal carcinomas: Cytogenetics and restriction fragment length polymorphism analysis , 1993, Genes, chromosomes & cancer.
[22] H. Gralnick,et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. , 1989, Journal of clinical pathology.
[23] S. Knuutila,et al. Cytogenetic and immunologic characterization of mitotic cells in chronic lymphocytic leukaemia , 1987, European journal of haematology.
[24] J W Gray,et al. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[25] Mark J. Thomas,et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.
[26] L. Aaltonen,et al. Complexity of 12q13-22 amplicon in liposarcoma: microsatellite repeat analysis. , 1997, Genes, chromosomes & cancer.
[27] F. Winston,et al. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. , 1987, Gene.
[28] D C Case,et al. Clinical staging of chronic lymphocytic leukemia. , 1977, The Journal of the Maine Medical Association.
[29] S. Lewis,et al. Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders , 2022 .